T11784 |
KT182
|
1402612-62-7
|
100%
|
|
KT182 is a selective and potent inhibitor of α/β-hydrolase domain containing 6 (ABHD6), with an IC50 of 0.24 nM in Neuro2A cells.
|
T17260 |
WWL70
|
947669-91-2
|
98.25%
|
|
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM).
|
T15635 |
JZP-430
|
1672691-74-5
|
98.31%
|
|
JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM). It also shows ~230-fold selectivity over fatty...
|
T11785 |
KT203
|
1402612-64-9
|
98.88%
|
|
KT203 is a selective and potent structural domain 6 (ABHD6) inhibitor of alpha/beta hydrolytic enzymes with potential antiviral and anti-inflammatory activity fo...
|
T22171 |
WWL123
|
1338575-41-9
|
99.44%
|
|
WWL123 is a potent and selective ABHD6 inhibitor (IC50=430 nM). WWL123 crosses the blood-brain-barrier and inhibits ABHD6 in brain parenchyma. ABHD6 blockade by ...
|
T8994 |
ML-226
|
2055172-43-3
|
99.61%
|
|
ML226 is a α/β hydrolase domain-containing protein 11 (ABHD11) inhibitor that inhibits ABHD11 in vitro and in situ.
|
T9374 |
AA38-3
|
65815-76-1
|
99.70%
|
|
AA38-3 (1-Piperidinecarboxylic acid, 4-nitrophenyl ester) inhibites three SHs (ABHD6, ABHD11, and FAAH)
|
T81881 |
MAGL-IN-10
|
|
98%
|
|
MAGL-IN-10, a reversible monoacylglycerol lipase (MAGL) inhibitor, exhibits favorable ADME properties and low in vivo toxicity. It is applicable in the study of ...
|
T81880 |
MAGL-IN-11
|
|
98%
|
|
MAGL-IN-11 (compound 29) is a selective, reversible inhibitor of monoacylglycerol lipase (MAGL), with potential in researching inflammation, cancer, and antioxid...
|
T81879 |
MAGL-IN-8
|
|
98%
|
|
MAGL-IN-8 (compound 13) serves as a reversible inhibitor of monoacylglycerol lipase (MAGL), exhibiting an inhibitory concentration half-maximal (IC50) value of 2...
|
T81878 |
MAGL-IN-9
|
|
98%
|
|
MAGL-IN-9, also referred to as compound 16, is a reversible inhibitor of monoacylglycerol lipase (MAGL) with a potent IC50 value of 2.7 nM [1].
|